An Active Surveillance Study to Monitor the Real-World Safety of Ritlecitinib Among Patients with Alopecia Areata in Denmark, France, and Sweden

21/05/2025
02/11/2026
EU PAS number:
EUPAS1000000512
Study
Planned
Documents
Study protocol
Initial protocol
English (792.62 KB - PDF) View document
Updated protocol
English (695.78 KB - PDF) View document
English (695.78 KB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.